NIDDM: Clinical Trials

1 trial for NIDDM, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow NIDDM: new trials by email Literature Review of NIDDM trials Research Report on NIDDM

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes
PF-04937319, Placebo - Diabetes Mellitus, Type 2, NIDDM
Phase 1CompletedPfizer612011-02-012017-02-01

Narrower conditions

Diabetes Mellitus, Type 2 (1)

Broader conditions

Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

N,N-dimethyl-5-((2-methyl-6-((5-methylpyrazin-2-yl)carbamoyl)benzofuran-4-yl)oxy)pyrimidine-2-carboxamide (1)

Sponsors

Pfizer (1)

Countries

United States (1)

Results publications

PMID 25142735